4550.T Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (10 nov 2022 @ 07:15):

Stats
Dagens volum	15 400.00
Gjennomsnittsvolum	0.00
Markedsverdi	0.00
Last Dividend	¥20.00 ( 2022-09-29 )
Next Dividend	¥0 ( N/A )
P/E	0.0000163
ATR14	¥0 (0.00%)

Nissui Pharmaceutical Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Nissui Pharmaceutical Økonomi

Annual	2022
Omsetning:	¥16.66B
Bruttogevinst:	¥5.26B (31.57 %)
EPS:	¥127 333 333

FY	2022
Omsetning:	¥16.66B
Bruttogevinst:	¥5.26B (31.57 %)
EPS:	¥127 333 333

FY	2021
Omsetning:	¥12.38B
Bruttogevinst:	¥4.20B (33.90 %)
EPS:	¥71 190 746

FY	2020
Omsetning:	¥12.77B
Bruttogevinst:	¥5.73B (44.83 %)
EPS:	¥44 054 372

Financial Reports:

No articles found.

Nissui Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥20.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Nissui Pharmaceutical Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 1.462 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥1.000	2001-03-27
Last Dividend	¥20.00	2022-09-29
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	38	--
Total Paid Out	¥454.00	--
Avg. Dividend % Per Year	0.00%	--
Score	3.24	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	1.462
Div. Directional Score	6.19	--

Next Divdend (Est)
(2024-12-09)

¥0 Estimate 0.00 %

Dividend Stability

0.09 Very Bad

Dividend Score

3.24

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8084.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
7408.T	Ex Dividend Junior	2024-03-28	Sporadic	0.00%
6629.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
5951.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
4641.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
3880.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
3109.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
1982.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
9994.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
8984.T	Ex Dividend Knight	2023-08-30	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0688	1.500	8.62	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0310	1.200	8.97	10.00	[0 - 0.3]
returnOnEquityTTM	0.0352	1.500	-0.720	-1.080	[0.1 - 1]
payoutRatioTTM	0.875	-1.000	1.248	-1.248	[0 - 1]
currentRatioTTM	8.29	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	1.255	0.800	7.32	5.86	[0.8 - 2.5]
cashRatioTTM	1.248	1.500	4.18	6.27	[0.2 - 2]
debtRatioTTM	0.00306	-1.500	9.95	-10.00	[0 - 0.6]
interestCoverageTTM	24.23	1.000	2.14	2.14	[3 - 30]
operatingCashFlowPerShareTTM	111 778 000	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	100 889 000	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.00347	-1.500	9.99	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.316	1.000	8.07	8.07	[0.2 - 0.8]
operatingProfitMarginTTM	0.103	1.000	9.93	9.93	[0.1 - 0.6]
cashFlowToDebtRatioTTM	8.90	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.451	0.800	-0.326	-0.261	[0.5 - 2]
Total Score				10.92

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	0.0000135	1.000	-0.101	0	[1 - 100]
returnOnEquityTTM	0.0352	2.50	-0.463	-1.080	[0.1 - 1.5]
freeCashFlowPerShareTTM	100 889 000	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	111 778 000	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0.875	1.500	1.248	-1.248	[0 - 1]
pegRatioTTM	-0.0000003	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0604	1.000	-0.990	0	[0.1 - 0.5]
Total Score				1.462

Nissui Pharmaceutical

Nissui Pharmaceutical Co., Ltd. produces, sells, imports, and exports culture media and diagnostics for medical institutions, research organizations, and food industries in Japan and internationally. It offers in vitro diagnostics and medical devices; culture media for microbiological testing; products for antimicrobial susceptibility tests, microorganism identification, and immunological tests; and quality control serum, which is used for ensuring the accuracy of clinical diagnoses. In addition,, the company provides microbiological testing products for food poisoning detection; immunosorbent assays for the detection of allergies to food items, such as eggs, wheat, milk, shrimp, crabs, buckwheat, peanuts, etc.; and culture media and reagents for regenerative medicine. Further, it supplies testing agents and bulk products to diagnostic agent manufacturers; and CompactDry, a dry medium that is used for coliform counting for food manufacturers. The company was formerly known as Nissan Research Institute Co., Ltd. and changed its name to Nissui Pharmaceutical Co., Ltd. in 1962. Nissui Pharmaceutical Co., Ltd. was founded in 1935 and is headquartered in Tokyo, Japan.